Octarine is a synthetic biology company producing functionally superior cannabinoids using engineered microbes. We have developed in-cell enzymatic platforms capable of making precise, stereospecific, and functionally relevant modifications to cannabinoid molecules to enhance their therapeutic and pharmacokinetic activity, expanding the chemical diversity of cannabinoid molecules beyond what is available in nature in ways that are impossible or infeasible to achieve using chemical synthesis.
Location København
Website octarinebio.com
Founded 2018
Employees 1-10
Industries Consumer Goods, Healthcare, High Tech, Impact Tech
Stage Product or prototype
Business model -